|
Meiqing Feng, Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Genetic Engineering | Drug Development | Application | Biotransformation | Natural Products | Research | Pharmaceutical | Technology | Innovation | Biomedical |
|
Ke Yu, Researcher, Doctoral Supervisor
Fudan University, Pharmaceutical Sciences
Area of Focus
Cancer | Targeted Therapy | Innovative Drugs | Signaling Pathways | Kinases | Cell Surface Receptors | Tumor Metabolism | Small Molecules | Monoclonal Antibodies | Drug Development |
|
Xiangbao Meng, Professor
Peking University , Pharmaceutical Sciences
Area of Focus
Immunomodulators | Small Molecules | Anti-Inflammatory | Drug Discovery | Optimization | Multi-Target | Drug-Resistant Tumors | Cancer | Inflammation | Immune Regulation |
|
Zhenjun Yang, Professor
Peking University , Pharmaceutical Sciences
Area of Focus
Natural Drugs | Biomimetic Drugs | Medicinal Chemistry | Pharmacy | Drug Development | Pharmacology | Organic Chemistry | Therapeutics | Pharmaceutical Sciences | Biomedical Research |
|
Demin Zhou, Doctoral Supervisor
Peking University , Pharmaceutical Sciences
Area of Focus
Drug Development | New Technologies | New Methods | Drug Targets | Biomarkers | Antiviral | Small Molecules | Protein Biopharmaceuticals | Discovery | Validation |
